Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives Rebecca MooreJoshua PoulsenJane B. Lane Commentary Open access 20 February 2024 Pages: 1305 - 1317
Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys Pamela R. KushnerJane DeMeisNavdeep Tangri Commentary Open access 05 March 2024 Pages: 1318 - 1324
Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review Natalie V. J. AldhouseHelen KitchenChristine L. Baker Review Open access 16 February 2024 Pages: 1325 - 1337
Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy LeighAnn Y. VincikAlexandra D. DautelAlan D. Kaye Review 20 February 2024 Pages: 1338 - 1350
An Update on Stiripentol Mechanisms of Action: A Narrative Review Alexandre BacqAntoine DepaulisMarc Verleye Review Open access 05 March 2024 Pages: 1351 - 1371
Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus José Manuel CarrascosaAna EcharriMaría Montoro Álvarez Original Research 07 February 2024 Pages: 1372 - 1384
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy Carla RognoniDomenica LorussoPatrizio Armeni Original Research Open access 08 February 2024 Pages: 1385 - 1400
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma Andrea BeverJessica DunneShelagh M. Szabo Original Research 13 February 2024 Pages: 1401 - 1418
Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study Adel AlharbiAbdullah YousefMatthieu Beuvelet Original Research Open access 15 February 2024 Pages: 1419 - 1435
Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective Fuming LiYingyao ChenYi Yang Original Research 15 February 2024 Pages: 1436 - 1449
Application of Northern Goshawk Back-Propagation Artificial Neural Network in the Prediction of Monohydroxycarbazepine Concentration in Patients with Epilepsy Yichao XuRong ShaoHaibin Dai Original Research 15 February 2024 Pages: 1450 - 1461
Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome Mona DarwishJulie PassarellKathie M. Bishop Original Research Open access 16 February 2024 Pages: 1462 - 1480
7-Year Efficacy and Safety of iStent inject Trabecular Micro-Bypass in Combined and Standalone Usage Fritz H. HengererGerd U. AuffarthIna Conrad-Hengerer Original Research Open access 16 February 2024 Pages: 1481 - 1495
Lutein and Zeaxanthin Supplementation Improves Dynamic Visual and Cognitive Performance in Children: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study Rajesh ParekhBilly R. Hammond Jr.Divya Chandradhara Original Research Open access 16 February 2024 Pages: 1496 - 1511
Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis Alissa RamsJessica BaldasaroEvangeline Pierce Original Research Open access 16 February 2024 Pages: 1512 - 1525
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan Takayuki HamanoYusuke YamaguchiTadao Akizawa Original Research Open access 16 February 2024 Pages: 1526 - 1552
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials Takayuki HamanoYusuke YamaguchiJonathan Barratt Original Research Open access 16 February 2024 Pages: 1553 - 1575
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma Hermann EinselePhilippe MoreauMaria-Victoria Mateos Original Research Open access 24 February 2024 Pages: 1576 - 1593
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands Juul M. P. A. van den ReekRobert J. T. van der LeestElke M. G. J. de Jong Original Research 24 February 2024 Pages: 1594 - 1605
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis André L. F. Azeredo-da-SilvaVictor Hugo F. de JesusPatricia K. Ziegelmann Original Research Open access 26 February 2024 Pages: 1606 - 1620
Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer Yan LiShengjie YangXinghe Wang Original Research 29 February 2024 Pages: 1621 - 1636
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies Nandita KheraMarie Louise EdwardsUsama Gergis Original Research Open access 01 March 2024 Pages: 1637 - 1651
Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH) Seung-June OhSung Tae ChoBudiwan Sumarsono Original Research Open access 02 March 2024 Pages: 1652 - 1671
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab Sanjay ChabraJulie BirtW. Chad Cragun Original Research Open access 05 March 2024 Pages: 1672 - 1684
Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome Hyun-Jin KimHyun-Sun Kim Original Research 05 March 2024 Pages: 1685 - 1697
Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis Yue PanXinxin ZhangLei Cheng Original Research 05 March 2024 Pages: 1698 - 1710
Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study Daniel J. SimmonsStephen J. ValerioJanvi Sah Original Research Open access 05 March 2024 Pages: 1711 - 1727
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study Motohiro OzoneSusumu HirotaNaohisa Uchimura Original Research Open access 09 March 2024 Pages: 1728 - 1745
Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials Brian MoseleyDimitrios BourikasSimon Borghs Brief Report Open access 15 February 2024 Pages: 1746 - 1758
Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China” Kun Huang Letter Open access 10 February 2024 Pages: 1759 - 1761
A Response to: Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China” Congling GuYi Han Letter Open access 10 February 2024 Pages: 1762 - 1764
Correction to: Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia Tawfeg Ben-OmranLuis MasanaRaul D. Santos Correction Open access 20 February 2024 Pages: 1765 - 1769
Correction to: Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients’ Real-World Insights for Optimizing Outcomes Bruce A. CowanKara OlivierJeffrey S. Wefel Correction Open access 11 January 2024 Pages: 1770 - 1773
Correction to: Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs Sana NiaziZisis GatzioufasFarideh Doroodgar Correction 02 March 2024 Pages: 1774 - 1774